<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-140712</identifier>
<setSpec>1135-8831</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Compliance with tuberculostatic therapy among patients seen at Hospital del Mar in Barcelona. Ten-year follow up</dc:title>
<dc:description xml:lang="en">Background. The success of tuberculostatic therapy correlates directly with compliance. Objective. To evaluate the compliance with tuberculostatic treatment among a group of children seen at a single institution. Method. 109 children receiving different tuberculostatic regimens were evaluated for compliance. The methods used included: 1) disclosure in response to direct and indirect questions; 2) colorimetric test for the presence of rifampin and isoniazid in urine. Results. Among the 36 cases of pulmonary tuberculosis, 3 patients were lost to follow-up and 27 patients have complied with all the follow-up visits. Of those, good therapeutic compliance was documented in 23 patients (71.8%), and it was estimated to be irregular in 4 patients. Thus, the overall compliance rate for patients with pulmonary tuberculosis was 81.25%. Among the 45 cases of latent tuberculosis infection, 2 patients were lot to follow-up, and 30 patients complied with all the follow-up visits. Of those, therapeutic compliance was good in 24 patients (55.8%), and it was irregular in 13 patients. Thus, the  overall compliance rate for patients with latent tuberculosis infection was 77.8%. Among the 28 patients receiving primary  chemoprophylaxis, therapeutic compliance wasgood in 15 patients, and irregular in 8 patients. Conclusions. 1) A good therapeutic compliance is very important to decrease the prevalence of tuberculois. The best method to improve compliance is direct supervision, which is not always feasible. 2) The compliance rates in our population (81.25% and 77.8%) are satisfactory, but could be improved. 3) The methodology used in our study is not optimal, but it is harmless, cheap and easy to perform. 4) It is essential that the primary pediatrician educates the patients on the severity of the disease and the importance of a good therapeutic compliance. 5) A stable health-care team facilitates the therapeutic compliance. 6) Short regimens are associated with better compliance  (AU)</dc:description>
<dc:creator>Cuesta, M José</dc:creator>
<dc:creator>Martínez-Roig, Antonio</dc:creator>
<dc:creator>Torruella, Meritxell</dc:creator>
<dc:creator>Salas-Sánchez, Esther</dc:creator>
<dc:creator>Sánchez-Sánchez, Xavier</dc:creator>
<dc:creator>Fernández, Olivia</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento. El éxito terapéutico tuberculostático se basa en el correcto cumplimiento. Objetivo. Valorar el cumplimiento de los tratamientos tuberculostáticos. Métodos. 109 niños. Metodología: 1) verbalización, preguntas directas e indirectas; 2) comprobación colorimétrica de la presència de rifampicina e isoniazida en orina. Resultados. Enfermedad tuberculosa: 36 casos (3 perdidos); 27 asisten a todas las visitas. Cumplimiento terapéutico en todas 23 (71.8%), irregular 4. Tasa de cumplimiento 81.25%. Infección tuberculosa: 45 (2 perdidos);  30 asisten a todas las visitas. Cumplimiento correcto 24 (55.8%); irregular 13. Tasa de cumplimiento 77.8%. Quimioprofilaxis primaria: 28. Cumplimiento correcto 15; irregular 8. Conclusiones. 1) El cumplimiento terapéutico es fundamental para la reducción de la tuberculosis. El mejor método es el tratamiento directamente observado, no siempre factible. 2) Las tasas de cumplimiento (81.25 y 77.8%) son aceptables pero mejorables. 3) La metodología para la valoración no es idónea, pero es inócua, fácil y de bajo costo. 4) Es imprescindible que el pediatra mentalice y eduque en la importancia de la enfermedad y el cumplimiento terapéutico. 5) Mantener el mismo equipo médico-enfermeria favorece la adherencia. 6) Con tratamientos cortos el cumplimiento es más fácil (AU)</dc:description>
<dc:source>Pediatr. catalan;63(1): 7-12, ene.-feb. 2003. tab</dc:source>
<dc:identifier>ibc-140712</dc:identifier>
<dc:title xml:lang="es">Cumplimiento del tratamiento tuberculostático entre la población atendida en el Hospital del Mar de Barcelona.  10 años de seguimiento</dc:title>
<dc:subject>^d14778^s22057</dc:subject>
<dc:subject>^d12705^s22050</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d7705^s22050</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d53262^s22083</dc:subject>
<dc:subject>^d28483</dc:subject>
<dc:subject>^d14778^s22080</dc:subject>
<dc:subject>^d999^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200302</dc:date>
</metadata>
</record>
</ibecs-document>
